# Study of DITPA in Patients With Congestive Heart Failure

> **NCT00103519** · PHASE2 · TERMINATED · sponsor: **Titan Pharmaceuticals** · enrollment: 86 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** DITPA (3,5-diiodothyropropionic acid)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00103519
- **Lead sponsor:** Titan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-12
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Study terminated for reasons unrelated to safety or efficacy.
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103519, "Study of DITPA in Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00103519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*